The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Role of the type III TGF-β receptor in modulating antitumor immunity during breast cancer progression.
B. A. Hanks
No relevant relationships to disclose
O. M. Campbell
No relevant relationships to disclose
J. D. Lee
No relevant relationships to disclose
M. Morse
No relevant relationships to disclose
T. M. Clay
No relevant relationships to disclose
H. K. Lyerly
No relevant relationships to disclose
G. C. Blobe
No relevant relationships to disclose